Company Innovus Pharmaceuticals Inc OTC Bulletin Board
Equities
US45778V1061
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01/18/01 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Mostafa Abuzeid
PRN | Corporate Officer/Principal | - | - |
Hans Christinger
PRN | Corporate Officer/Principal | - | - |
Gilbert Jaoudé
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,204,401 | 2,483,540 ( 77.50 %) | 0 | 77.50 % |
Company contact information
Innovus Pharmaceuticals, Inc.
373 Inverness Parkway Suite 206
80112, Englewood
+858-964-5123
http://www.innovuspharma.comSector
1st Jan change | Capi. | |
---|---|---|
+55.04% | 81TCr | |
+44.25% | 65TCr | |
-6.32% | 35TCr | |
+21.98% | 34TCr | |
+10.81% | 30TCr | |
+18.45% | 25TCr | |
+2.09% | 23TCr | |
+13.03% | 22TCr | |
+9.07% | 17TCr |
- Stock Market
- Equities
- Stock
- Stock
- Company Innovus Pharmaceuticals Inc